Classical Swine Fever Vaccines Industry Research Report 2025

Summary

It is a type of vaccine for classical swine fever. Classical swine fever (CSF), also known as hog cholera, is a contagious viral disease of pigs, including wild boar. The causative virus is a member of the genus Pestivirus of the family Flaviviridae, and is closely related to the viruses of bovine viral diarrhoea and border disease. There is only one serotype of CSF virus (CSFV).

According to APO Research, the global Classical Swine Fever Vaccines market was valued at US$ million in 2024 and is anticipated to reach US$ million by 2031, witnessing a CAGR of xx% during the forecast period 2025-2031.

North American market for Classical Swine Fever Vaccines is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Classical Swine Fever Vaccines is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Europe market for Classical Swine Fever Vaccines is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global manufacturers of Classical Swine Fever Vaccines include WINSUN, Merial, CAHIC, Chopper Biology, MSD Animal Health (Merck), ChengDu Tecbond, Ceva, Harbin Veterinary Research Institute and Qilu Animal Health Products Factory, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Classical Swine Fever Vaccines, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Classical Swine Fever Vaccines.

The report will help the Classical Swine Fever Vaccines manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

The Classical Swine Fever Vaccines market size, estimations, and forecasts are provided in terms of sales volume (M Doses) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Classical Swine Fever Vaccines market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

Key Companies & Market Share Insights

In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2020-2025. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses.

Classical Swine Fever Vaccines Segment by Company

WINSUN
Merial
CAHIC
Chopper Biology
MSD Animal Health (Merck)
ChengDu Tecbond
Ceva
Harbin Veterinary Research Institute
Qilu Animal Health Products Factory
Ringpu Biology
DHN
CAVAC
Komipharm
Agrovet
Bioveta
Jinyu Bio-Technology
Institutul Pasteur
MVP
Tecon

Classical Swine Fever Vaccines Segment by Source
Tissue Culture Origin
Cell Line Origin

Classical Swine Fever Vaccines Segment by Sales Channel
Government Tender
Market Sales

Classical Swine Fever Vaccines Segment by Region

North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Classical Swine Fever Vaccines market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Classical Swine Fever Vaccines and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Classical Swine Fever Vaccines.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Classical Swine Fever Vaccines manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Classical Swine Fever Vaccines by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Classical Swine Fever Vaccines in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by source, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by sales channel, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.

Please Note: Single-User license will be delivered via PDF from the publisher without the rights to print or to edit.


1 Preface
1.1 Scope of Report
1.2 Reasons for Doing This Study
1.3 Research Methodology
1.4 Research Process
1.5 Data Source
1.5.1 Secondary Sources
1.5.2 Primary Sources
2 Market Overview
2.1 Product Definition
2.2 Global Market Growth Prospects
2.2.1 Global Classical Swine Fever Vaccines Market Size (2020-2031)
2.2.2 Global Classical Swine Fever Vaccines Sales (2020-2031)
2.2.3 Global Classical Swine Fever Vaccines Market Average Price (2020-2031)
2.3 Classical Swine Fever Vaccines by Source
2.3.1 Market Value Comparison by Source (2020 VS 2024 VS 2031) & (US$ Million)
2.3.2 Tissue Culture Origin
2.3.3 Cell Line Origin
2.4 Classical Swine Fever Vaccines by Sales Channel
2.4.1 Market Value Comparison by Sales Channel (2020 VS 2024 VS 2031)
2.4.2 Government Tender
2.4.3 Market Sales
3 Market Competitive Landscape by Manufacturers
3.1 Global Classical Swine Fever Vaccines Market Competitive Situation by Manufacturers (2020 Versus 2024)
3.2 Global Classical Swine Fever Vaccines Sales (M Doses) of Manufacturers (2020-2025)
3.3 Global Classical Swine Fever Vaccines Revenue of Manufacturers (2020-2025)
3.4 Global Classical Swine Fever Vaccines Average Price by Manufacturers (2020-2025)
3.5 Global Classical Swine Fever Vaccines Industry Ranking, 2023 VS 2024 VS 2025
3.6 Global Manufacturers of Classical Swine Fever Vaccines, Manufacturing Sites & Headquarters
3.7 Global Manufacturers of Classical Swine Fever Vaccines, Product Type & Application
3.8 Global Manufacturers of Classical Swine Fever Vaccines, Established Date
3.9 Global Classical Swine Fever Vaccines Market CR5 and HHI
3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
4.1 WINSUN
4.1.1 WINSUN Company Information
4.1.2 WINSUN Business Overview
4.1.3 WINSUN Classical Swine Fever Vaccines Sales, Revenue and Gross Margin (2020-2025)
4.1.4 WINSUN Classical Swine Fever Vaccines Product Portfolio
4.1.5 WINSUN Recent Developments
4.2 Merial
4.2.1 Merial Company Information
4.2.2 Merial Business Overview
4.2.3 Merial Classical Swine Fever Vaccines Sales, Revenue and Gross Margin (2020-2025)
4.2.4 Merial Classical Swine Fever Vaccines Product Portfolio
4.2.5 Merial Recent Developments
4.3 CAHIC
4.3.1 CAHIC Company Information
4.3.2 CAHIC Business Overview
4.3.3 CAHIC Classical Swine Fever Vaccines Sales, Revenue and Gross Margin (2020-2025)
4.3.4 CAHIC Classical Swine Fever Vaccines Product Portfolio
4.3.5 CAHIC Recent Developments
4.4 Chopper Biology
4.4.1 Chopper Biology Company Information
4.4.2 Chopper Biology Business Overview
4.4.3 Chopper Biology Classical Swine Fever Vaccines Sales, Revenue and Gross Margin (2020-2025)
4.4.4 Chopper Biology Classical Swine Fever Vaccines Product Portfolio
4.4.5 Chopper Biology Recent Developments
4.5 MSD Animal Health (Merck)
4.5.1 MSD Animal Health (Merck) Company Information
4.5.2 MSD Animal Health (Merck) Business Overview
4.5.3 MSD Animal Health (Merck) Classical Swine Fever Vaccines Sales, Revenue and Gross Margin (2020-2025)
4.5.4 MSD Animal Health (Merck) Classical Swine Fever Vaccines Product Portfolio
4.5.5 MSD Animal Health (Merck) Recent Developments
4.6 ChengDu Tecbond
4.6.1 ChengDu Tecbond Company Information
4.6.2 ChengDu Tecbond Business Overview
4.6.3 ChengDu Tecbond Classical Swine Fever Vaccines Sales, Revenue and Gross Margin (2020-2025)
4.6.4 ChengDu Tecbond Classical Swine Fever Vaccines Product Portfolio
4.6.5 ChengDu Tecbond Recent Developments
4.7 Ceva
4.7.1 Ceva Company Information
4.7.2 Ceva Business Overview
4.7.3 Ceva Classical Swine Fever Vaccines Sales, Revenue and Gross Margin (2020-2025)
4.7.4 Ceva Classical Swine Fever Vaccines Product Portfolio
4.7.5 Ceva Recent Developments
4.8 Harbin Veterinary Research Institute
4.8.1 Harbin Veterinary Research Institute Company Information
4.8.2 Harbin Veterinary Research Institute Business Overview
4.8.3 Harbin Veterinary Research Institute Classical Swine Fever Vaccines Sales, Revenue and Gross Margin (2020-2025)
4.8.4 Harbin Veterinary Research Institute Classical Swine Fever Vaccines Product Portfolio
4.8.5 Harbin Veterinary Research Institute Recent Developments
4.9 Qilu Animal Health Products Factory
4.9.1 Qilu Animal Health Products Factory Company Information
4.9.2 Qilu Animal Health Products Factory Business Overview
4.9.3 Qilu Animal Health Products Factory Classical Swine Fever Vaccines Sales, Revenue and Gross Margin (2020-2025)
4.9.4 Qilu Animal Health Products Factory Classical Swine Fever Vaccines Product Portfolio
4.9.5 Qilu Animal Health Products Factory Recent Developments
4.10 Ringpu Biology
4.10.1 Ringpu Biology Company Information
4.10.2 Ringpu Biology Business Overview
4.10.3 Ringpu Biology Classical Swine Fever Vaccines Sales, Revenue and Gross Margin (2020-2025)
4.10.4 Ringpu Biology Classical Swine Fever Vaccines Product Portfolio
4.10.5 Ringpu Biology Recent Developments
4.11 DHN
4.11.1 DHN Company Information
4.11.2 DHN Business Overview
4.11.3 DHN Classical Swine Fever Vaccines Sales, Revenue and Gross Margin (2020-2025)
4.11.4 DHN Classical Swine Fever Vaccines Product Portfolio
4.11.5 DHN Recent Developments
4.12 CAVAC
4.12.1 CAVAC Company Information
4.12.2 CAVAC Business Overview
4.12.3 CAVAC Classical Swine Fever Vaccines Sales, Revenue and Gross Margin (2020-2025)
4.12.4 CAVAC Classical Swine Fever Vaccines Product Portfolio
4.12.5 CAVAC Recent Developments
4.13 Komipharm
4.13.1 Komipharm Company Information
4.13.2 Komipharm Business Overview
4.13.3 Komipharm Classical Swine Fever Vaccines Sales, Revenue and Gross Margin (2020-2025)
4.13.4 Komipharm Classical Swine Fever Vaccines Product Portfolio
4.13.5 Komipharm Recent Developments
4.14 Agrovet
4.14.1 Agrovet Company Information
4.14.2 Agrovet Business Overview
4.14.3 Agrovet Classical Swine Fever Vaccines Sales, Revenue and Gross Margin (2020-2025)
4.14.4 Agrovet Classical Swine Fever Vaccines Product Portfolio
4.14.5 Agrovet Recent Developments
4.15 Bioveta
4.15.1 Bioveta Company Information
4.15.2 Bioveta Business Overview
4.15.3 Bioveta Classical Swine Fever Vaccines Sales, Revenue and Gross Margin (2020-2025)
4.15.4 Bioveta Classical Swine Fever Vaccines Product Portfolio
4.15.5 Bioveta Recent Developments
4.16 Jinyu Bio-Technology
4.16.1 Jinyu Bio-Technology Company Information
4.16.2 Jinyu Bio-Technology Business Overview
4.16.3 Jinyu Bio-Technology Classical Swine Fever Vaccines Sales, Revenue and Gross Margin (2020-2025)
4.16.4 Jinyu Bio-Technology Classical Swine Fever Vaccines Product Portfolio
4.16.5 Jinyu Bio-Technology Recent Developments
4.17 Institutul Pasteur
4.17.1 Institutul Pasteur Company Information
4.17.2 Institutul Pasteur Business Overview
4.17.3 Institutul Pasteur Classical Swine Fever Vaccines Sales, Revenue and Gross Margin (2020-2025)
4.17.4 Institutul Pasteur Classical Swine Fever Vaccines Product Portfolio
4.17.5 Institutul Pasteur Recent Developments
4.18 MVP
4.18.1 MVP Company Information
4.18.2 MVP Business Overview
4.18.3 MVP Classical Swine Fever Vaccines Sales, Revenue and Gross Margin (2020-2025)
4.18.4 MVP Classical Swine Fever Vaccines Product Portfolio
4.18.5 MVP Recent Developments
4.19 Tecon
4.19.1 Tecon Company Information
4.19.2 Tecon Business Overview
4.19.3 Tecon Classical Swine Fever Vaccines Sales, Revenue and Gross Margin (2020-2025)
4.19.4 Tecon Classical Swine Fever Vaccines Product Portfolio
4.19.5 Tecon Recent Developments
5 Global Classical Swine Fever Vaccines Market Scenario by Region
5.1 Global Classical Swine Fever Vaccines Market Size by Region: 2020 VS 2024 VS 2031
5.2 Global Classical Swine Fever Vaccines Sales by Region: 2020-2031
5.2.1 Global Classical Swine Fever Vaccines Sales by Region: 2020-2025
5.2.2 Global Classical Swine Fever Vaccines Sales by Region: 2026-2031
5.3 Global Classical Swine Fever Vaccines Revenue by Region: 2020-2031
5.3.1 Global Classical Swine Fever Vaccines Revenue by Region: 2020-2025
5.3.2 Global Classical Swine Fever Vaccines Revenue by Region: 2026-2031
5.4 North America Classical Swine Fever Vaccines Market Facts & Figures by Country
5.4.1 North America Classical Swine Fever Vaccines Market Size by Country: 2020 VS 2024 VS 2031
5.4.2 North America Classical Swine Fever Vaccines Sales by Country (2020-2031)
5.4.3 North America Classical Swine Fever Vaccines Revenue by Country (2020-2031)
5.4.4 United States
5.4.5 Canada
5.4.6 Mexico
5.5 Europe Classical Swine Fever Vaccines Market Facts & Figures by Country
5.5.1 Europe Classical Swine Fever Vaccines Market Size by Country: 2020 VS 2024 VS 2031
5.5.2 Europe Classical Swine Fever Vaccines Sales by Country (2020-2031)
5.5.3 Europe Classical Swine Fever Vaccines Revenue by Country (2020-2031)
5.5.4 Germany
5.5.5 France
5.5.6 U.K.
5.5.7 Italy
5.5.8 Russia
5.5.9 Spain
5.5.10 Netherlands
5.5.11 Switzerland
5.5.12 Sweden
5.5.13 Poland
5.6 Asia Pacific Classical Swine Fever Vaccines Market Facts & Figures by Country
5.6.1 Asia Pacific Classical Swine Fever Vaccines Market Size by Country: 2020 VS 2024 VS 2031
5.6.2 Asia Pacific Classical Swine Fever Vaccines Sales by Country (2020-2031)
5.6.3 Asia Pacific Classical Swine Fever Vaccines Revenue by Country (2020-2031)
5.6.4 China
5.6.5 Japan
5.6.6 South Korea
5.6.7 India
5.6.8 Australia
5.6.9 Taiwan
5.6.10 Southeast Asia
5.7 South America Classical Swine Fever Vaccines Market Facts & Figures by Country
5.7.1 South America Classical Swine Fever Vaccines Market Size by Country: 2020 VS 2024 VS 2031
5.7.2 South America Classical Swine Fever Vaccines Sales by Country (2020-2031)
5.7.3 South America Classical Swine Fever Vaccines Revenue by Country (2020-2031)
5.7.4 Brazil
5.7.5 Argentina
5.7.6 Chile
5.8 Middle East and Africa Classical Swine Fever Vaccines Market Facts & Figures by Country
5.8.1 Middle East and Africa Classical Swine Fever Vaccines Market Size by Country: 2020 VS 2024 VS 2031
5.8.2 Middle East and Africa Classical Swine Fever Vaccines Sales by Country (2020-2031)
5.8.3 Middle East and Africa Classical Swine Fever Vaccines Revenue by Country (2020-2031)
5.8.4 Egypt
5.8.5 South Africa
5.8.6 Israel
5.8.7 Türkiye
5.8.8 GCC Countries
6 Segment by Source
6.1 Global Classical Swine Fever Vaccines Sales by Source (2020-2031)
6.1.1 Global Classical Swine Fever Vaccines Sales by Source (2020-2031) & (M Doses)
6.1.2 Global Classical Swine Fever Vaccines Sales Market Share by Source (2020-2031)
6.2 Global Classical Swine Fever Vaccines Revenue by Source (2020-2031)
6.2.1 Global Classical Swine Fever Vaccines Sales by Source (2020-2031) & (US$ Million)
6.2.2 Global Classical Swine Fever Vaccines Revenue Market Share by Source (2020-2031)
6.3 Global Classical Swine Fever Vaccines Price by Source (2020-2031)
7 Segment by Sales Channel
7.1 Global Classical Swine Fever Vaccines Sales by Sales Channel (2020-2031)
7.1.1 Global Classical Swine Fever Vaccines Sales by Sales Channel (2020-2031) & (M Doses)
7.1.2 Global Classical Swine Fever Vaccines Sales Market Share by Sales Channel (2020-2031)
7.2 Global Classical Swine Fever Vaccines Revenue by Sales Channel (2020-2031)
7.2.1 Global Classical Swine Fever Vaccines Sales by Sales Channel (2020-2031) & (US$ Million)
7.2.2 Global Classical Swine Fever Vaccines Revenue Market Share by Sales Channel (2020-2031)
7.3 Global Classical Swine Fever Vaccines Price by Sales Channel (2020-2031)
8 Value Chain and Sales Channels Analysis of the Market
8.1 Classical Swine Fever Vaccines Value Chain Analysis
8.1.1 Classical Swine Fever Vaccines Key Raw Materials
8.1.2 Raw Materials Key Suppliers
8.1.3 Classical Swine Fever Vaccines Production Mode & Process
8.2 Classical Swine Fever Vaccines Sales Channels Analysis
8.2.1 Direct Comparison with Distribution Share
8.2.2 Classical Swine Fever Vaccines Distributors
8.2.3 Classical Swine Fever Vaccines Customers
9 Global Classical Swine Fever Vaccines Analyzing Market Dynamics
9.1 Classical Swine Fever Vaccines Industry Trends
9.2 Classical Swine Fever Vaccines Industry Drivers
9.3 Classical Swine Fever Vaccines Industry Opportunities and Challenges
9.4 Classical Swine Fever Vaccines Industry Restraints
10 Report Conclusion
11 Disclaimer

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings